NEUROTECH INTERNATIONAL LIMITED - Announcements

7.69%

1.4¢

Market Cap $14.69M

Healthcare Biotechnology

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

NTI	Neurotech Secures $3.56m in Funding	PRICE SENSITIVE	02/03/21	165.7KB	Share
NTI	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	26/02/21	661.89KB	Share
NTI	Trading Halt	PRICE SENSITIVE	26/02/21	173.33KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/01/21	369.81KB	Share
NTI	Successful Completion of In Vitro Studies	PRICE SENSITIVE	21/12/20	384.21KB	Share
NTI	Disclosure Document	PRICE SENSITIVE	16/12/20	454.41KB	Share
NTI	Reinstatement to Official Quotation	PRICE SENSITIVE	30/11/20	402.35KB	Share
NTI	Further Success with Preliminary In-vitro Studies	PRICE SENSITIVE	30/11/20	128.54KB	Share
NTI	Voluntary Suspension	PRICE SENSITIVE	27/11/20	159.73KB	Share
NTI	Trading Halt	PRICE SENSITIVE	24/11/20	480.17KB	Share
NTI	Disclosure Document	PRICE SENSITIVE	06/11/20	386.42KB	Share
NTI	Interim Results and Capital Raising	PRICE SENSITIVE	02/11/20	103.57KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	02/11/20	347.47KB	Share
NTI	Trading Halt	PRICE SENSITIVE	29/10/20	143.63KB	Share
NTI	Response to ASX Price and Volume Query	PRICE SENSITIVE	22/10/20	208.6KB	Share
NTI	Neurotech Proceeds to in vitro trials after Positive Results	PRICE SENSITIVE	07/09/20	472.55KB	Share
NTI	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/20	718.09KB	Share
NTI	Disclosure Document	PRICE SENSITIVE	26/08/20	422.17KB	Share
NTI	Response to ASX price query	PRICE SENSITIVE	21/08/20	657.35KB	Share
NTI	Pause in Trading	PRICE SENSITIVE	21/08/20	113.83KB	Share
NTI	Promising Early Results from Cannabinoid Analysis	PRICE SENSITIVE	21/08/20	136.93KB	Share
NTI	Trading Halt	PRICE SENSITIVE	19/08/20	156.17KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/07/20	453.14KB	Share
NTI	Disclosure Document	PRICE SENSITIVE	15/07/20	374.05KB	Share
NTI	NTI Secures Option to Cannabis Strains Targeting Autism	PRICE SENSITIVE	03/07/20	143.12KB	Share
NTI	Trading Halt	PRICE SENSITIVE	01/07/20	328.64KB	Share
NTI	Reinstatement to Official Quotation	PRICE SENSITIVE	01/05/20	71.3KB	Share
NTI	Response to ASX Price and Volume Query	PRICE SENSITIVE	01/05/20	241.53KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/04/20	280.75KB	Share
NTI	Suspension from Official Quotation	PRICE SENSITIVE	14/04/20	183.29KB	Share
NTI	Mente receives CE Mark renewal for use with ASD Children	PRICE SENSITIVE	09/04/20	170.22KB	Share
NTI	Trading Halt	PRICE SENSITIVE	08/04/20	213.23KB	Share
NTI	Pause In Trade	PRICE SENSITIVE	08/04/20	115.74KB	Share
NTI	Appendix 4D & Half Year Report	PRICE SENSITIVE	25/02/20	394.5KB	Share
NTI	Response to Appendix 4C Query	PRICE SENSITIVE	17/02/20	268.3KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	03/02/20	327.11KB	Share
NTI	Cancellation of Mente Device from Australian TGA Register	PRICE SENSITIVE	28/01/20	97.39KB	Share
NTI	Trading Halt	PRICE SENSITIVE	24/01/20	155.47KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/19	198.79KB	Share
NTI	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	30/08/19	715.77KB	Share
NTI	Quarterly Update & Appendix 4C	PRICE SENSITIVE	31/07/19	279.41KB	Share
NTI	Response to ASX Price and Volume Query	PRICE SENSITIVE	18/07/19	252.46KB	Share
NTI	Response to ASX Price and Volume Query	PRICE SENSITIVE	05/06/19	669.72KB	Share
NTI	Response to ASX Price and Volume Query	PRICE SENSITIVE	29/05/19	192.56KB	Share
NTI	Pause In Trading	PRICE SENSITIVE	29/05/19	116.2KB	Share
NTI	Quarterly Activities and Cashflow Report	PRICE SENSITIVE	30/04/19	323.18KB	Share
NTI	Response to ASX Price Query	PRICE SENSITIVE	24/04/19	414.61KB	Share
NTI	Dr Adrian Attard Trevisan	PRICE SENSITIVE	27/03/19	122.01KB	Share
NTI	Appendix 4D and 31 December 2018 Half Year Report	PRICE SENSITIVE	28/02/19	1.01MB	Share
NTI	RENOUNCEABLE PRO-RATA RIGHTS ISSUE	PRICE SENSITIVE	25/02/19	126.97KB	Share
NTI	Supplementary Prospectus	PRICE SENSITIVE	07/02/19	126.71KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/19	498.23KB	Share
NTI	Prospectus - Renounceable Rights Issue	PRICE SENSITIVE	29/01/19	398.28KB	Share
NTI	Investor Presentation	PRICE SENSITIVE	29/01/19	1.06MB	Share
NTI	Neurotech Rights Issue	PRICE SENSITIVE	29/01/19	227.03KB	Share
NTI	Appointment of Peter Griffiths as CEO	PRICE SENSITIVE	26/11/18	158.62KB	Share
NTI	New Appointments	PRICE SENSITIVE	23/10/18	189.26KB	Share
NTI	Quarterly report	PRICE SENSITIVE	19/10/18	2.87MB	Share
NTI	Shipment of Mente Autism devices	PRICE SENSITIVE	04/10/18	219.17KB	Share
NTI	Mente Autism - FDA Clearance Application	PRICE SENSITIVE	02/10/18	169.98KB	Share
NTI	Appendix 4E and Annual Report	PRICE SENSITIVE	03/09/18	945.04KB	Share
NTI	First Shipments of Mente Autism	PRICE SENSITIVE	10/08/18	186.77KB	Share
NTI	Quarterly report and Appendix 4C	PRICE SENSITIVE	31/07/18	427.62KB	Share
NTI	US Clinical Trial Results Published	PRICE SENSITIVE	09/07/18	1.73MB	Share
NTI	Trading Halt	PRICE SENSITIVE	05/07/18	352.7KB	Share
NTI	Mente Autism Approval From Italcert	PRICE SENSITIVE	04/06/18	169.99KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/18	370.77KB	Share
NTI	Appendix 4D and 31 December 2017 Half Year Financial Report	PRICE SENSITIVE	28/02/18	439.78KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/01/18	783.6KB	Share
NTI	Indian Distribution Agreement	PRICE SENSITIVE	18/01/18	582.09KB	Share
NTI	Design Agreement with eemagine	PRICE SENSITIVE	27/11/17	578.27KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/17	906.16KB	Share
NTI	Reinstatement to Official Quotation	PRICE SENSITIVE	16/10/17	251.67KB	Share
NTI	Capital Raising Completed	PRICE SENSITIVE	16/10/17	595.56KB	Share
NTI	Suspension from Official Quotation	PRICE SENSITIVE	12/10/17	559.91KB	Share
NTI	Trading Halt	PRICE SENSITIVE	11/10/17	764.02KB	Share
NTI	Response to ASX Query	PRICE SENSITIVE	03/10/17	916.91KB	Share
NTI	Clinical Trial Preliminary Outcomes	PRICE SENSITIVE	27/09/17	619.33KB	Share
NTI	Trading Halt	PRICE SENSITIVE	25/09/17	531.65KB	Share
NTI	Distributor Update	PRICE SENSITIVE	14/09/17	604.91KB	Share
NTI	Appendix 4E	PRICE SENSITIVE	01/09/17	365.03KB	Share
NTI	Italian Distributor Update	PRICE SENSITIVE	21/08/17	476.74KB	Share
NTI	Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/07/17	794.83KB	Share
NTI	Neurotech completes Turkey shipment	PRICE SENSITIVE	10/07/17	638.08KB	Share
NTI	Neurotech renews Turkey distribution agreement	PRICE SENSITIVE	26/06/17		Share
NTI	Distribution Update	PRICE SENSITIVE	19/06/17	498.83KB	Share
NTI	Mente Autism Update	PRICE SENSITIVE	05/06/17	600.32KB	Share
NTI	US Clinical Trial Update	PRICE SENSITIVE	29/05/17	591.33KB	Share
NTI	First Shipment to Greece	PRICE SENSITIVE	25/05/17	600.17KB	Share
NTI	Distribution Update	PRICE SENSITIVE	22/05/17	583.41KB	Share
NTI	FDA Update	PRICE SENSITIVE	12/05/17	475.69KB	Share
NTI	Quarterly Reports	PRICE SENSITIVE	26/04/17	2.78MB	Share
NTI	Distribution Partner Update	PRICE SENSITIVE	26/04/17	477.23KB	Share
NTI	FDA Pre submission and World Autism Awareness Day	PRICE SENSITIVE	30/03/17	490.57KB	Share
NTI	US Clinical Trial Update	PRICE SENSITIVE	29/03/17	483KB	Share
NTI	Mente Pro Update	PRICE SENSITIVE	09/03/17	597.39KB	Share
NTI	Austrian Distribution Partner	PRICE SENSITIVE	02/03/17	480.5KB	Share
NTI	Half Year Report and Accounts	PRICE SENSITIVE	01/03/17	1.2MB	Share
NTI	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	281.51KB	Share
NTI	Mente Autism Shipment	PRICE SENSITIVE	22/12/16	488.44KB	Share

NTI Neurotech Secures $3.56m in Funding
02/03/21	PRICE SENSITIVE	165.7KB	Share
NTI Appendix 4D and Half Year Accounts
26/02/21	PRICE SENSITIVE	661.89KB	Share
NTI Trading Halt
26/02/21	PRICE SENSITIVE	173.33KB	Share
NTI Quarterly Report and Appendix 4C
29/01/21	PRICE SENSITIVE	369.81KB	Share
NTI Successful Completion of In Vitro Studies
21/12/20	PRICE SENSITIVE	384.21KB	Share
NTI Disclosure Document
16/12/20	PRICE SENSITIVE	454.41KB	Share
NTI Reinstatement to Official Quotation
30/11/20	PRICE SENSITIVE	402.35KB	Share
NTI Further Success with Preliminary In-vitro Studies
30/11/20	PRICE SENSITIVE	128.54KB	Share
NTI Voluntary Suspension
27/11/20	PRICE SENSITIVE	159.73KB	Share
NTI Trading Halt
24/11/20	PRICE SENSITIVE	480.17KB	Share
NTI Disclosure Document
06/11/20	PRICE SENSITIVE	386.42KB	Share
NTI Interim Results and Capital Raising
02/11/20	PRICE SENSITIVE	103.57KB	Share
NTI Quarterly Report and Appendix 4C
02/11/20	PRICE SENSITIVE	347.47KB	Share
NTI Trading Halt
29/10/20	PRICE SENSITIVE	143.63KB	Share
NTI Response to ASX Price and Volume Query
22/10/20	PRICE SENSITIVE	208.6KB	Share
NTI Neurotech Proceeds to in vitro trials after Positive Results
07/09/20	PRICE SENSITIVE	472.55KB	Share
NTI Appendix 4E and Annual Report
31/08/20	PRICE SENSITIVE	718.09KB	Share
NTI Disclosure Document
26/08/20	PRICE SENSITIVE	422.17KB	Share
NTI Response to ASX price query
21/08/20	PRICE SENSITIVE	657.35KB	Share
NTI Pause in Trading
21/08/20	PRICE SENSITIVE	113.83KB	Share
NTI Promising Early Results from Cannabinoid Analysis
21/08/20	PRICE SENSITIVE	136.93KB	Share
NTI Trading Halt
19/08/20	PRICE SENSITIVE	156.17KB	Share
NTI Quarterly Report and Appendix 4C
30/07/20	PRICE SENSITIVE	453.14KB	Share
NTI Disclosure Document
15/07/20	PRICE SENSITIVE	374.05KB	Share
NTI NTI Secures Option to Cannabis Strains Targeting Autism
03/07/20	PRICE SENSITIVE	143.12KB	Share
NTI Trading Halt
01/07/20	PRICE SENSITIVE	328.64KB	Share
NTI Reinstatement to Official Quotation
01/05/20	PRICE SENSITIVE	71.3KB	Share
NTI Response to ASX Price and Volume Query
01/05/20	PRICE SENSITIVE	241.53KB	Share
NTI Quarterly Report and Appendix 4C
29/04/20	PRICE SENSITIVE	280.75KB	Share
NTI Suspension from Official Quotation
14/04/20	PRICE SENSITIVE	183.29KB	Share
NTI Mente receives CE Mark renewal for use with ASD Children
09/04/20	PRICE SENSITIVE	170.22KB	Share
NTI Trading Halt
08/04/20	PRICE SENSITIVE	213.23KB	Share
NTI Pause In Trade
08/04/20	PRICE SENSITIVE	115.74KB	Share
NTI Appendix 4D & Half Year Report
25/02/20	PRICE SENSITIVE	394.5KB	Share
NTI Response to Appendix 4C Query
17/02/20	PRICE SENSITIVE	268.3KB	Share
NTI Quarterly Report and Appendix 4C
03/02/20	PRICE SENSITIVE	327.11KB	Share
NTI Cancellation of Mente Device from Australian TGA Register
28/01/20	PRICE SENSITIVE	97.39KB	Share
NTI Trading Halt
24/01/20	PRICE SENSITIVE	155.47KB	Share
NTI Quarterly Report and Appendix 4C
31/10/19	PRICE SENSITIVE	198.79KB	Share
NTI Appendix 4E and Annual Report to Shareholders
30/08/19	PRICE SENSITIVE	715.77KB	Share
NTI Quarterly Update & Appendix 4C
31/07/19	PRICE SENSITIVE	279.41KB	Share
NTI Response to ASX Price and Volume Query
18/07/19	PRICE SENSITIVE	252.46KB	Share
NTI Response to ASX Price and Volume Query
05/06/19	PRICE SENSITIVE	669.72KB	Share
NTI Response to ASX Price and Volume Query
29/05/19	PRICE SENSITIVE	192.56KB	Share
NTI Pause In Trading
29/05/19	PRICE SENSITIVE	116.2KB	Share
NTI Quarterly Activities and Cashflow Report
30/04/19	PRICE SENSITIVE	323.18KB	Share
NTI Response to ASX Price Query
24/04/19	PRICE SENSITIVE	414.61KB	Share
NTI Dr Adrian Attard Trevisan
27/03/19	PRICE SENSITIVE	122.01KB	Share
NTI Appendix 4D and 31 December 2018 Half Year Report
28/02/19	PRICE SENSITIVE	1.01MB	Share
NTI RENOUNCEABLE PRO-RATA RIGHTS ISSUE
25/02/19	PRICE SENSITIVE	126.97KB	Share
NTI Supplementary Prospectus
07/02/19	PRICE SENSITIVE	126.71KB	Share
NTI Quarterly Report and Appendix 4C
31/01/19	PRICE SENSITIVE	498.23KB	Share
NTI Prospectus - Renounceable Rights Issue
29/01/19	PRICE SENSITIVE	398.28KB	Share
NTI Investor Presentation
29/01/19	PRICE SENSITIVE	1.06MB	Share
NTI Neurotech Rights Issue
29/01/19	PRICE SENSITIVE	227.03KB	Share
NTI Appointment of Peter Griffiths as CEO
26/11/18	PRICE SENSITIVE	158.62KB	Share
NTI New Appointments
23/10/18	PRICE SENSITIVE	189.26KB	Share
NTI Quarterly report
19/10/18	PRICE SENSITIVE	2.87MB	Share
NTI Shipment of Mente Autism devices
04/10/18	PRICE SENSITIVE	219.17KB	Share
NTI Mente Autism - FDA Clearance Application
02/10/18	PRICE SENSITIVE	169.98KB	Share
NTI Appendix 4E and Annual Report
03/09/18	PRICE SENSITIVE	945.04KB	Share
NTI First Shipments of Mente Autism
10/08/18	PRICE SENSITIVE	186.77KB	Share
NTI Quarterly report and Appendix 4C
31/07/18	PRICE SENSITIVE	427.62KB	Share
NTI US Clinical Trial Results Published
09/07/18	PRICE SENSITIVE	1.73MB	Share
NTI Trading Halt
05/07/18	PRICE SENSITIVE	352.7KB	Share
NTI Mente Autism Approval From Italcert
04/06/18	PRICE SENSITIVE	169.99KB	Share
NTI Quarterly Report and Appendix 4C
30/04/18	PRICE SENSITIVE	370.77KB	Share
NTI Appendix 4D and 31 December 2017 Half Year Financial Report
28/02/18	PRICE SENSITIVE	439.78KB	Share
NTI Quarterly Report and Appendix 4C
30/01/18	PRICE SENSITIVE	783.6KB	Share
NTI Indian Distribution Agreement
18/01/18	PRICE SENSITIVE	582.09KB	Share
NTI Design Agreement with eemagine
27/11/17	PRICE SENSITIVE	578.27KB	Share
NTI Quarterly Report and Appendix 4C
31/10/17	PRICE SENSITIVE	906.16KB	Share
NTI Reinstatement to Official Quotation
16/10/17	PRICE SENSITIVE	251.67KB	Share
NTI Capital Raising Completed
16/10/17	PRICE SENSITIVE	595.56KB	Share
NTI Suspension from Official Quotation
12/10/17	PRICE SENSITIVE	559.91KB	Share
NTI Trading Halt
11/10/17	PRICE SENSITIVE	764.02KB	Share
NTI Response to ASX Query
03/10/17	PRICE SENSITIVE	916.91KB	Share
NTI Clinical Trial Preliminary Outcomes
27/09/17	PRICE SENSITIVE	619.33KB	Share
NTI Trading Halt
25/09/17	PRICE SENSITIVE	531.65KB	Share
NTI Distributor Update
14/09/17	PRICE SENSITIVE	604.91KB	Share
NTI Appendix 4E
01/09/17	PRICE SENSITIVE	365.03KB	Share
NTI Italian Distributor Update
21/08/17	PRICE SENSITIVE	476.74KB	Share
NTI Quarterly Report and Appendix 4C
31/07/17	PRICE SENSITIVE	794.83KB	Share
NTI Neurotech completes Turkey shipment
10/07/17	PRICE SENSITIVE	638.08KB	Share
NTI Neurotech renews Turkey distribution agreement
26/06/17	PRICE SENSITIVE		Share
NTI Distribution Update
19/06/17	PRICE SENSITIVE	498.83KB	Share
NTI Mente Autism Update
05/06/17	PRICE SENSITIVE	600.32KB	Share
NTI US Clinical Trial Update
29/05/17	PRICE SENSITIVE	591.33KB	Share
NTI First Shipment to Greece
25/05/17	PRICE SENSITIVE	600.17KB	Share
NTI Distribution Update
22/05/17	PRICE SENSITIVE	583.41KB	Share
NTI FDA Update
12/05/17	PRICE SENSITIVE	475.69KB	Share
NTI Quarterly Reports
26/04/17	PRICE SENSITIVE	2.78MB	Share
NTI Distribution Partner Update
26/04/17	PRICE SENSITIVE	477.23KB	Share
NTI FDA Pre submission and World Autism Awareness Day
30/03/17	PRICE SENSITIVE	490.57KB	Share
NTI US Clinical Trial Update
29/03/17	PRICE SENSITIVE	483KB	Share
NTI Mente Pro Update
09/03/17	PRICE SENSITIVE	597.39KB	Share
NTI Austrian Distribution Partner
02/03/17	PRICE SENSITIVE	480.5KB	Share
NTI Half Year Report and Accounts
01/03/17	PRICE SENSITIVE	1.2MB	Share
NTI Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	281.51KB	Share
NTI Mente Autism Shipment
22/12/16	PRICE SENSITIVE	488.44KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change 0.001(7.69%)		Mkt cap ! $14.69M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$15.72K	1.129M

Buyers (Bids)

No.	Vol.	Price($)
4	839752	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	1528971	4

View Market Depth

No.	Vol.	Price($)
4	839752	0.013
12	3230644	0.012
7	2028725	0.011
8	2120000	0.010
1	100000	0.009

Price($)	Vol.	No.
0.014	1528971	4
0.015	365204	4
0.016	495817	6
0.017	268623	2
0.018	563001	4

Last trade - 13.47pm 03/09/2025 (20 minute delay)


Last 1.4¢		Change 0.001 ( 7.69 %)
Open	High	Low	Volume
1.3¢	1.4¢	1.3¢	67048
Last updated 14.06pm 03/09/2025 ?

NTI (ASX) Chart

NEUROTECH INTERNATIONAL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories